share_log

Ensysce Biosciences Regains Full Nasdaq Compliance

Ensysce Biosciences Regains Full Nasdaq Compliance

Ensysce Biosciences 恢复完全的纳斯达克合规性
Benzinga ·  2024/12/23 21:21

Meeting Minimum Bid Price And Stockholders' Equity Requirements; Common Stock To Continue Trading On Nasdaq Capital Market

满足最低出价和股东权益要求;普通股将继续在纳斯达克资本市场上交易

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发